|Bid||0.00 x 1200|
|Ask||80.00 x 2200|
|Day's range||71.85 - 72.75|
|52-week range||52.51 - 80.71|
|PE ratio (TTM)||34.29|
|Earnings date||30 Jul 2018 - 3 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||79.72|
DaVita Inc (NYSE:DVA) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. With many analysts covering the large-cap stock, we mayRead More...
The firm was among several potential buyers including large retailers, strategic health-care partners and venture-capital and private equity firms.
With Morgan Stanley calling clinical laboratory services market a safe haven, let's find out what's working in favor and against this burgeoning niche market.
The Denver-based company said it had net income of 98 cents per share. Earnings, adjusted to account for discontinued operations, came to $1.05 per share. The results topped Wall Street expectations. The ...
Disruptors are circling the health-care industry. UnitedHealth Group Inc., the biggest U.S. health insurer, has built an army of tens of thousands of physicians to fend off invaders.
Davita's kidney care unit is gaining prominence worldwide. However, the company is grappling with labor-union woes in California and Ohio.
Let's put DaVita (DVA) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Stocks that moved substantially or traded heavily on Tuesday: Qualcomm Inc., down $3.11 to $59.70 President Donald Trump blocked Broadcom's effort to buy the rival chipmaker, citing national security concerns. ...
On a per-share basis, the Denver-based company said it had net income of $1.64. Earnings, adjusted for one-time gains and costs, were 92 cents per share. The results exceeded Wall Street expectations. ...
DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.
A Texas-based pharmacy chain that specializes in patients with kidney problems will pay nearly $64 million to settle allegations of improper billing and other disputed financial practices. Federal prosecutors ...